NEK2 and neoplasm: Gene mutations, DNA amplification and promoter methylation status are the major causes for aberrantly high expression of candidate tumor genes.[17a,17] Previous studies focused on the function, mechanisms and protein stability of NEK2, but how NEK2 is activated and upregulated remained poorly understood.